FLSJarrel
Networker
We are having a discusion in our office about whether both a spirometry (94010) & a methacholine bronchoprovocation challenge study (94070) can both be billed when performed on the same day. The Spirometry was performed at 12:10, while the challenge was performed at 13:15. Only one Hospital report with the test results was generated including the numbers for both procedures. Our MD then interpreted the results generating two reports as follows:
Spirometry:
PULMONARY FUNCTION TEST
Spirometry shows normal FEV1 to FVC ratio of 86%. FEV1 is normal at 3.26, 114%. FVC is also normal at 3.76, 106%.
IMPRESSION: Normal spirometry.
Challenge:
PULMONARY FUNCTION TEST
This is a methacholine bronchoprovocation challenge study to evaluate for inducible reactive airways obstruction.
The patient is a Caucasian female who is 64 inches tall and weighs 222 pounds. Prior to methacholine challenge study, the patient had a normal spirometry. The patient underwent incremental increases of inhaled methacholine from zero with normal saline to a high dose of 10 mg/mL inhaled methacholine. The patient did not demonstrate any inducible airway obstruction. The FEV1, however, had an inducible small airways reaction at the highest dose at minus 44%. This reducible airway obstruction was resolved with stop of study and a dose of bronchodilator.
IMPRESSION: Small airways inducible obstruction, manifested as decreased function in FEF25-75%. This is consistent with very, very mild asthma at this level. This obstruction was resolved with therapy with short-acting bronchodilators.
Are both of these billable? Or is the spirometry reading included in the challege?
Any help in determining the answer would be greatly appreciated. Thanks.
Spirometry:
PULMONARY FUNCTION TEST
Spirometry shows normal FEV1 to FVC ratio of 86%. FEV1 is normal at 3.26, 114%. FVC is also normal at 3.76, 106%.
IMPRESSION: Normal spirometry.
Challenge:
PULMONARY FUNCTION TEST
This is a methacholine bronchoprovocation challenge study to evaluate for inducible reactive airways obstruction.
The patient is a Caucasian female who is 64 inches tall and weighs 222 pounds. Prior to methacholine challenge study, the patient had a normal spirometry. The patient underwent incremental increases of inhaled methacholine from zero with normal saline to a high dose of 10 mg/mL inhaled methacholine. The patient did not demonstrate any inducible airway obstruction. The FEV1, however, had an inducible small airways reaction at the highest dose at minus 44%. This reducible airway obstruction was resolved with stop of study and a dose of bronchodilator.
IMPRESSION: Small airways inducible obstruction, manifested as decreased function in FEF25-75%. This is consistent with very, very mild asthma at this level. This obstruction was resolved with therapy with short-acting bronchodilators.
Are both of these billable? Or is the spirometry reading included in the challege?
Any help in determining the answer would be greatly appreciated. Thanks.